Skip to Main Content

Paper Details

Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study.
Diabetes Obes Metab
4
2023
ACE-I, ASCVD, GLP-1, OMT, Patients, SGLT2i, angiotensin II receptor, angiotensin receptor neprilysin, angiotensin-converting enzyme, atherosclerotic cardiovascular disease, cardiologists, cholesterol, coronary disease, diabetes, ezetimibe, glucagon-like peptide-1 receptor, glucose, kexin, low-density lipoprotein-cholesterol, patient, patients, proprotein, sodium-, sodium-glucose co-transporter-2, statin, subtilisin, type 1 diabetes, type 2 diabetes
Author NameAffiliation
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
Deepak L BhattIcahn School of Medicine at Mount Sinai Health System
Christopher P CannonBaim Institute for Clinical Research
Christopher P CannonIcahn School of Medicine at Mount Sinai Health System
Mikhail KosiborodSaint Luke's Mid America Heart Institute and University of Missouri-Kansas City
Mikhail KosiborodThe George Institute for Global Health
  • 1 - 7

Datasets

Release 1.2